
Predicting the origin of azoospermia with non‐invasive biomarkers is clinically relevant for determining the chance of successful sperm retrieval from the testes before attempting assisted reproduction treatment. In this study, the semen small extracellular vesicle microRNA miR‐31‐5p‐based biomarker test to distinguish obstructive azoospermia from secretory azoospermia is validated for clinical use. Findings indicate that the use of total seminal plasma as an analytical sample would facilitate the use of a simplified technical procedure for miR‐31‐5p quantification. In addition, it would significantly improve reproductive treatment decision protocols for azoospermia in clinical practice.
Like
Save
Share